GC Pharma's cartel fine appeal heads to Constitutional Court review in South Korea
South Korea's GC Pharmaceutical will get another chance to challenge a Supreme Court ruling that upheld a 2023 vaccine cartel fine, as the country's Constitutional Court takes up the case under...To view the full article, register now.
Already a subscriber? Click here to view full article